Allergy immunotherapy (AIT) is a causal treatment that addresses the underlying cause of allergies, not just the symptoms, and is the only disease‐modifying treatment for allergic conditions.
It is the only therapy that has demonstrated the capacity not only to improve symptoms, reduce the need for medications, but also to induce specific tolerance beyond the duration of the treatment and to prevent the development of new allergic conditions.
AIT involves the repeated administration of specific allergen extracts to an allergic individual. By targeting the specific allergens that trigger a patient’s symptoms, AIT inhibits the occurrence of both seasonal and perennial allergic reactions, to provide long-term relief of symptoms and improvement in their quality of life.
